Reuters logo
BRIEF-Novabay Pharmaceuticals reports Q3 loss per share $0.16
2017年11月14日 / 晚上9点36分 / 8 天前

BRIEF-Novabay Pharmaceuticals reports Q3 loss per share $0.16

Nov 14 (Reuters) - Novabay Pharmaceuticals Inc:

* Novabay Pharmaceuticals reports third quarter 2017 financial results

* Q3 loss per share $0.16

* Sees FY 2017 sales up 47 to 55 percent

* Sees FY 2017 sales $17.5 million to $18.5 million

* Q3 sales $4.1 million versus I/B/E/S view $4.8 million

* Q3 earnings per share view $-0.09 -- Thomson Reuters I/B/E/S

* Novabay Pharmaceuticals - ‍affirming guidance for 2017 gross profit margin on Avenova sales to be in high 80pct range​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below